Viral IL-10 gene transfer inhibits DTH responses to soluble antigens: Evidence for involvement of genetically modified dendritic cells and macrophages

Molecular Therapy

Volumn 4, Issue 6, 2001, Pages 543-550

  Whalen, Janey D ^a   Thomson, Angus W ^b   Lu, Lina ^b   Robbins, Paul D ^a   Evans, Christopher H ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antigen presentation; Arthritis; Autoimmunity; Contralateral effect; Dendritic cell; Immunomodulation; Lymphocyte; Macrophage; Adoptive transfer

Indexed keywords

ANTIGEN; DNA; RECOMBINANT INTERLEUKIN 10; VIRUS VECTOR;

ADENOVIRUS; ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; DNA MODIFICATION; DONOR; DRUG MECHANISM; FOOT PAD; GENE THERAPY; GENE TRANSFER; IMMUNE RESPONSE; LYMPH NODE; LYMPHATIC DRAINAGE; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM EXUDATE; RECIPIENT; SENSITIZATION; T LYMPHOCYTE;

ADENOVIRIDAE; ANIMALIA;

EID: 0035668081     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2001.0492     Document Type: Article

References (27)

1. Gene therapy for rheumatic diseases
2. Gene therapy for autoimmune disorders
3. Future of adenoviruses in the gene therapy of arthritis
4. Direct adenovirus mediated gene transfer of interleukin 1 and tumor necrosis factor α soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects
5. Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus mediated delivery of interleukin-4
6. Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws
7. Direct adenoviral gene transfer of viral II 10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees
8. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI
9. Immunosuppressive and anti-inflammatory properties of interleukin 10
10. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity
11. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo
12. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte derived IL-10
13. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
14. IL-10 inhibits cytokine production by activated macrophages
15. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
16. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones
17. Manipulation of Th1/Th2 balance in vivo by adoptive transfer of antigen specific Th1 or Th2 cells
18. Distribution late and mechanism of immune modulation following mucosal delivery of plasmid DNA encoding IL-10
19. Modulation of virus induced delayed-type hypersensitivity by plasmid DNA encoding the cytokine interleukin-10
20. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function
21. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
22. A critical role for transforming growth factor-β but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells
23. Induction of tolerance by IL-10-treated dendritic cells
24. Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4
25. Differential effects of exogenous interleukin-10 on cardiac allograft survival: Inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function
26. Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1 dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes
27. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival